NCNA NCNA
Company Profile ↓Company Overview
NCNA (NCNA) is a publicly traded company listed on with a market capitalization of $27.89B. The valuation, growth and price-trend signals below summarize what matters most to investors and traders evaluating the stock.
Growth & Price Performance
Stock Price Performance
| 1 Year: | -85.43% |
| 6 Months: | -44.17% |
| 3 Months: | -38.81% |
| 1 Month: | -3.60% |
- Price vs 50-DMABelow
- Price vs 200-DMABelow
- RSI (14)45.16 · Neutral
Auto-generated from price history and fundamentals; not investment advice.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth Charts
No fundamental data available for this stock.
Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.
PROS
No notable strengths flagged.
CONS
- Trading 85.4% below its 52-week high.
- In a downtrend (50-DMA below 200-DMA).
* The pros and cons are auto-generated from financial metrics.
Valuation
Growth (CAGR)
Profitability & Returns
Balance Sheet & Liquidity
Ownership
Financial Snapshot
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios
Quarterly Results
Figures in USD.
| Metric | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 |
| Cost of Revenue | - | - | - | - | - |
| Gross Profit | - | - | - | - | - |
| Operating Expenses | 2.79M | 11.63M | 3.57M | 2.84M | 4.78M |
| Operating Income | -2.79M | -11.63M | -3.57M | -2.84M | -4.78M |
| EBITDA | -2.73M | -11.56M | -3.50M | -2.77M | -4.71M |
| Interest Expense | - | - | - | - | - |
| Pretax Income | -2.83M | -24.44M | -626.00K | -2.63M | -4.28M |
| Tax Provision | -353.00K | -328.00K | -345.00K | -142.00K | -410.00K |
| Net Income | -2.47M | -24.11M | -281.00K | -2.48M | -3.87M |
| Diluted EPS | -100.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Profit & Loss (Annual)
Figures in USD.
| Metric | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 |
| Cost of Revenue | - | - | - | - |
| Gross Profit | - | - | - | - |
| Operating Expenses | 43.72M | 31.12M | 23.00M | 20.83M |
| Operating Income | -43.72M | -31.12M | -23.00M | -20.83M |
| EBITDA | -42.98M | -30.55M | -22.48M | -20.56M |
| Interest Expense | - | - | - | - |
| Pretax Income | -38.45M | -32.03M | -22.45M | -30.52M |
| Tax Provision | -6.43M | -4.40M | -3.45M | -1.17M |
| Net Income | -32.02M | -27.63M | -19.00M | -29.35M |
| Diluted EPS | -3,050.00 | -2,650.00 | -1,300.00 | 0.00 |
Balance Sheet (Annual)
Figures in USD.
| Metric | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Total Assets | - | 58.25M | 27.81M | 14.77M | 29.83M |
| Current Assets | - | 54.92M | 25.02M | 12.27M | 26.86M |
| Cash & Equivalents | - | 41.91M | 17.23M | 6.75M | 24.25M |
| Inventory | - | - | - | - | - |
| Receivables | - | 7.02M | 5.83M | 4.64M | 1.86M |
| Total Liabilities | - | 19.75M | 12.92M | 8.82M | 5.51M |
| Current Liabilities | - | 19.31M | 12.68M | 8.67M | 4.79M |
| Long Term Debt | - | - | - | - | - |
| Total Debt | - | 639.00K | 396.00K | 190.00K | 676.00K |
| Total Equity | - | 38.50M | 14.89M | 5.95M | 24.33M |
| Shares Outstanding | - | 52.37M | 52.86M | 142.04M | 20.81B |
Cash Flows (Annual)
Figures in USD.
| Metric | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Operating Cash Flow | - | -23.16M | -26.44M | -19.12M | -7.47M |
| Investing Cash Flow | - | 120.00K | 2.89M | 79.00K | 159.00K |
| Financing Cash Flow | - | -161.00K | -53.00K | 8.18M | 25.01M |
| Capital Expenditure | - | -518.00K | -478.00K | -293.00K | -193.00K |
| Free Cash Flow | - | -23.68M | -26.92M | -19.41M | -7.66M |
| Net Change in Cash | - | -23.20M | -23.60M | -10.86M | 17.70M |
Ratios (Annual)
Figures in %.
| Metric | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|
| Gross Margin % | - | - | - | - |
| Operating Margin % | - | - | - | - |
| Net Margin % | - | - | - | - |
| ROE % | -83.2% | -185.6% | -319.1% | -120.7% |
| ROCE % | -112.3% | -205.6% | -376.6% | -83.2% |
Shareholding Pattern
Analyst View
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for NCNA
NCNA - Finviz
<a href="https://news.google.com/rss/articles/CBMiRkFVX3lxTFBjbjhRbzFTS0M5U0JOcUtDWEJpNFFBOHJUTUJGUEpsNnl2MnFnNS1yaUtDRHB6cmtfS3VuM2s4bnZUMnlicVE?oc=5" target="_blank">NCNA</a> <font color="#6f6f6f">Finviz</font>…
NuCana Shareholders Approve All Resolutions at June 2026 AGM - theglobeandmail.com
<a href="https://news.google.com/rss/articles/CBMi3gFBVV95cUxQVlNPaEJWTXZSVVRNaVpVUWttQjRQeEZES25JN2MteTRwNkFhbW1qcFE2UjZNLWRxaG8tZDM5WkxmZVM2QVFyTzllMEFFNi1CVGs0Q29jWkFsUjFVSkl6WGsyTnNrdVkwVEE1cWp6bGQ4QWhaT2NadkZIcU40dHRCNXVnVHRDYjlmVFF1T0…
NuCana (NCNA) CMO cancels 36.5M vested options, retains 109.6M - Stock Titan
<a href="https://news.google.com/rss/articles/CBMiqAFBVV95cUxQR2VmQWZWOElwTTJyRVpPWkF5aHFoVUpSSmVrLTJ4cFc1YU9tTm5IZ1FaNmN5NlZmdi1jZktZbjdpT2RqTWtVNUpYY0R1RlVKV0NaOHhxV2VFQndsN0NNMExXa1ZMOGpmUXZmLU9rdkxXZS00aU52cjFaYy1qY1U1N1FXVm9PdThSXzRwYW…
NCNA|NuCana PLC|Price:1.280|Chg%:+0.020 - TradingKey
<a href="https://news.google.com/rss/articles/CBMibkFVX3lxTE9rbGMwbWxGM0V2M3pMTm5oY3ptYUpYUUxjTzFQa08zRW15a3NtOHVtMEdoM3Vla1dKMXliUUd2SnBEZkpHZllCSl9URDcwaHJWOEJKc1N0U1VaMVBkbThnTDhSdVUyUndRT2Z4MUJR?oc=5" target="_blank">NCNA|NuCana PLC|Pri…
symbol__ Stock Quote Price and Forecast - CNN
<a href="https://news.google.com/rss/articles/CBMiUEFVX3lxTFBDWXo3YW1OakhHbDY0RF9udndndWlYTVNEOU16UTJjQlZ1N3dpRGFPODdKcUF5eUxZRWhHYlF6dURwNHRKQnY3b2F3X2VkdGtv?oc=5" target="_blank">symbol__ Stock Quote Price and Forecast</a> <fon…
NuCana plc (NCNA) Shows Resilience: Modest Uptick Amid Biotech Volatility - Virgin POC - po-news-eg.net
<a href="https://news.google.com/rss/articles/CBMiswFBVV95cUxQSmRPNnNVLTlvNEdRSGUyYmlLZFRVY0pWdHdQUlRHenB2c1lYWkF3eEZGTUVJNHJOSTNWUHg2dDV5YXF0Wk1kZ0xOdUQxWHdmSWNaQXJ5aW1DLTFUOHNYbTdKYW13S3FNVVZLZXZvZE52bVpIRnVZR3BQZDEtWnNnSnExVXlrMWNabFZNVU…
NCNA — Frequently Asked Questions
What is the current share price of NCNA?
As of 2026-08-05 17:25 PDT, NCNA trades at $1.34 on NASDAQ/NYSE. Its 52-week range is $1.21 to $9.20.
What is the market capitalisation of NCNA?
NCNA has a market capitalisation of $27.89B on NASDAQ/NYSE.
What is the return on equity (ROE) of NCNA?
NCNA has a return on equity (ROE) of -120.66%. Its return on capital employed (ROCE) is -83.20%.
Is NCNA a good stock to buy?
This page provides a data-driven analysis of NCNA, including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.